Peripheral Nervous System DiseasesDiabetic NeuropathiesSural NerveNeural ConductionPeripheral NervesPolyneuropathiesHereditary Sensory and Motor NeuropathyCharcot-Marie-Tooth DiseaseSciatic NerveAlcoholic NeuropathyPeripheral Nervous SystemHereditary Sensory and Autonomic NeuropathiesParesthesiaMononeuropathiesOptic Neuropathy, IschemicMyelin P0 ProteinAutonomic Nervous System DiseasesPaclitaxelSchwann CellsNeuralgiaElectrodiagnosisDiagnostic Techniques, NeurologicalHypesthesiaDemyelinating DiseasesNeurologic ExaminationNervous System DiseasesHyperalgesiaPeroneal NerveAmyloid NeuropathiesTibial NerveDiabetic FootUlnar NeuropathiesMedian NerveMyelin ProteinsSensationNeuritisNerve FibersElectromyographyBoronic AcidsOrganoplatinum CompoundsFoot UlcerSensation DisordersTreatment OutcomePyrazinesAxonsAntineoplastic Agents, PhytogenicMyelin SheathFootGanglia, SpinalPainPolyradiculoneuropathyNeuromuscular DiseasesCranial Nerve DiseasesTime FactorsVasa NervorumEpothilonesUlnar NerveNeurotoxicity SyndromesPeroneal NeuropathiesCryoglobulinemiaParaneoplastic PolyneuropathyPeripheral Nerve InjuriesAtaxiaSciatic NeuropathySensory Receptor CellsPain MeasurementSeverity of Illness IndexDisease Models, AnimalFemoral NeuropathyStavudineMotor NeuronsReflex, AbnormalThalidomideDrug Administration SchedulePeripheral Vascular DiseasesOptic Atrophy, Hereditary, LeberArthropathy, NeurogenicVasculitisAntineoplastic AgentsOptic Nerve DiseasesAcetylcarnitineGuillain-Barre SyndromeMedian NeuropathyAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesPain ThresholdBrachial Plexus NeuropathiesPrevalenceRats, Sprague-DawleySensory ThresholdsCerebellar AtaxiaProspective StudiesChurg-Strauss SyndromeDiabetes Mellitus, Type 2Tibial NeuropathyParaproteinemiasBiopsyDose-Response Relationship, DrugForefoot, HumanRisk Factors